Is RLMD undervalued or overvalued?

As of 2025-03-26, the Intrinsic Value of Relmada Therapeutics Inc (RLMD) is -16.41 USD. This RLMD valuation is based on the model Peter Lynch Fair Value. With the current market price of 0.30 USD, the upside of Relmada Therapeutics Inc is -5,534.11%. This means that RLMD is overvalued by 5,534.11%.

Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.

	Range	Selected	Upside
a
Fair Value	-16.41 - -16.41	-16.41	-5,534.11%
DDM - Stable	(23.07) - (108.64)	(65.85)	-21906.0%
DDM - Multi	(24.54) - (92.77)	(39.14)	-13061.5%